- Pfizer is ranked 1st in Australia/New Zealand area and general 2nd in Asia in its company popularity from a affected person perspective
- Asian affected person teams have positioned the pharma trade 1st for company popularity in Asia amongst different healthcare sectors
SINGAPORE, Aug. 26, 2022 /PRNewswire/ — Pfizer has been ranked first in its Covid-19 response, affected person centricity, affected person security and bringing progressive, high-quality merchandise amongst pharma corporations in Asia within the ‘Corporate Reputation of Pharma’ survey by affected person teams throughout the APAC area. Overall, the corporate is ranked second for its company popularity throughout Asian nations and areas.
Pfizer moved up within the survey rankings from 4th place to occupy the highest rating from affected person teams ‘working’ with Pfizer, representing a big enhance in rankings in 2021 vs. 2020.
This survey, performed by UK-based PatientView, measures numerous elements of pharma’s efficiency at company popularity from a affected person perspective. Patient teams responding to this survey are working throughout therapeutic areas and uniquely positioned to touch upon the pharma trade’s efficiency in the course of the pandemic.
Opinions from 300 affected person teams from throughout Asia (Hong Kong, Taiwan, India, Malaysia, Philippines, Australia, S.Korea, mainland China and others) have been collected on the efficiency of the pharmaceutical trade in 2021. They have collectively been in communication with almost 2.7 million Asian sufferers in 2021. A complete of 31 pharmaceutical corporations have been assessed within the Asia version of this survey.
Asian affected person teams conversant in and/or working with Pfizer assessed the corporate to have considerably improved its scores throughout all indicators of company popularity in 2021.
Pharma’s efficiency at creating vaccines at velocity in response to the Covid-19 pandemic satisfied a lot of the respondents of the trade’s and Pfizer’s effectiveness at each innovation and skill to ship merchandise that really profit sufferers.
"Patients are our North Star. From the earliest stage of drug development to the final approval and use of our medicines and vaccines, our purpose is breakthroughs that change patients’ lives. We work with, and for, patients, advocates, and caregivers to meet the evolving needs of patients everywhere. Colleagues across Pfizer collaborate with patients and patient advocates to develop breakthrough treatments and innovative approaches to help address patient challenges. These partnerships have helped to increase patient engagement in research and development, diversify clinical trials, develop patient-friendly educational materials and patient support programs, and elevate priority policy and social impact issues. Patients are the focus of everything we do. Everything we do is intended to help patients everywhere live longer and healthier lives", mentioned Mr. Anil Argilla, President, Emerging Markets Asia, Pfizer Biopharmaceuticals Group, Pfizer Inc.
The outcomes of the pharma company popularity survey (Asia) can be found at: https://www.patient-view.com/wp-content/uploads/2022/08/PATIENTVIEW-PRESS-RELEASE-CORP-REP-Asia-final.pdf.
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our world sources to convey therapies to folks that reach and considerably enhance their lives. We try to set the usual for high quality, security and worth within the discovery, growth and manufacture of well being care merchandise, together with progressive medicines and vaccines. Every day, Pfizer colleagues work throughout developed and rising markets to advance wellness, prevention, remedies and cures that problem probably the most feared illnesses of our time. Consistent with our accountability as one of many world’s premier progressive biopharmaceutical corporations, we collaborate with well being care suppliers, governments and native communities to assist and develop entry to dependable, inexpensive well being care around the globe. For greater than 170 years, now we have labored to make a distinction for all who depend on us.
